Your browser doesn't support javascript.
loading
MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB.
Zhang, Zhen; Zhang, Luoyan; Wang, Bin; Wei, Ran; Wang, Yunxia; Wan, Jipeng; Zhang, Chi; Zhao, Lin; Zhu, Xiaoxiao; Zhang, Yunhong; Chu, Chu; Guo, Qiang; Yin, Xunqiang; Li, Xia.
Afiliação
  • Zhang Z; Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Zhang L; Key Lab of Plant Stress Research, College of Life Science, Shandong Normal University, Jinan, 250014, Shandong, China.
  • Wang B; Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
  • Wei R; Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Wang Y; Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
  • Wan J; Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
  • Zhang C; Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
  • Zhao L; Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Zhu X; Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Zhang Y; Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, 18877 Jingshi Road, Jinan, 250062, S
  • Chu C; Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, 18877 Jingshi Road, Jinan, 250062, S
  • Guo Q; Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Yin X; Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, 18877 Jingshi Road, Jinan, 250062, S
  • Li X; Laboratory for Molecular Immunology, Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China. Electronic address: 786735868@qq.com.
Cancer Lett ; 469: 54-67, 2020 01 28.
Article em En | MEDLINE | ID: mdl-31629932
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / MicroRNAs / Classe I de Fosfatidilinositol 3-Quinases / Carcinoma Epitelial do Ovário Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Middle aged Idioma: En Revista: Cancer Lett Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Irlanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / MicroRNAs / Classe I de Fosfatidilinositol 3-Quinases / Carcinoma Epitelial do Ovário Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Middle aged Idioma: En Revista: Cancer Lett Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Irlanda